Infliximab
Tumor necrosis factor (TNF-alpha) binding antibody (chimeric IgG1). It is composed of human constant and murine variable regions. Infliximab is produced by a recombinant cell line cultured by continuous perfusion
| Trivial name | IGHG1 |
| Catalog Number | TP-088CL |
| Alternative Name(s) | Infliximab |
| Research Area | Immunoregulation |
| Molecular Formula | C6428H9912N1694O1987S46 |
| CAS# | 170277-31-3 |
| Purity | >90% |
| Size | 1 mg |
| Supplier Page | https://www.creativebiolabs.net/Infliximab-22426.htm |
| Additional Information | To manage the signs and symptoms, as well as to induce and maintain clinical remission in adults with moderate to severe active Crohn's disease or ulcerative colitis. Also used to manage signs and symptoms of rheumatoid arthritis (in conjunction with methotrexate), ankylosing spondylitis, psoriatic arthritis, and juvenile arthritis. |